The Second Appellate District affirmed an order. The court held that a preliminary injunction based on issue sanctions against a party who repeatedly violated discovery orders by the trial court was not an abuse of discretion.
NewLife Sciences, LLC (NLS), manufactured, marketed, and leased to physicians a pain relief device called a therapeutic magnetic resonance device (TMR). The Food and Drug Administration (FDA) had cleared the use of the device for certain medical purposes after NLS had acquired all the rights to the TMR. The use of a TMR without physician supervision violated FDA rules.
